The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
Open accessAbstract
Methotrexate is used to treat autoimmune diseases and malignancies, including acute lymphoblastic leukemia (ALL). Inter-individual variation in clearance of methotrexate results in heterogeneous systemic exposure, clinical efficacy, and toxicity. In a genome-wide association study of children with ALL, we identified SLCO1B1 as harboring multiple common polymorphisms associated with methotrexate clearance. The extent of influence of rare versus common variants on pharmacogenomic phenotypes remains largely unexplored. We tested the hypothesis that rare variants in SLCO1B1 could affect methotrexate clearance and compared the influence of common versus rare variants in addition to clinical covariates on clearance. From deep resequencing of SLCO1B1 exons in 699 children, we identified 93 SNPs, 15 of which were non-synonymous (NS). Three of these NS SNPs were common, with a minor allele frequency (MAF) >5%, one had low frequency (MAF 1%–5%), and 11 were rare (MAF <1%). NS SNPs (common or rare) predicted to be functionally damaging were more likely to be found among patients with the lowest methotrexate clearance than patients with high clearance. We verified lower function in vitro of four SLCO1B1 haplotypes that were associated with reduced methotrexate clearance. In a multivariate stepwise regression analysis adjusting for other genetic and non-genetic covariates, SLCO1B1 variants accounted for 10.7% of the population variability in clearance. Of that variability, common NS variants accounted for the majority, but rare damaging NS variants constituted 17.8% of SLCO1B1's effects (1.9% of total variation) and had larger effect sizes than common NS variants. Our results show that rare variants are likely to have an important effect on pharmacogenetic phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inference of Population Structure Using Multilocus Genotype Data
Pritchard, J. K., Stephens, M., & Donnelly, P. (2000) · Genetics · doi:10.1093/genetics/155.2.945 · Cited by 33,908
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
A New Statistical Method for Haplotype Reconstruction from Population Data
Stephens, M., Smith, N. J., & Donnelly, P. (2001) · The American Journal of Human Genetics · doi:10.1086/319501 · Cited by 7,493
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Predicting Deleterious Amino Acid Substitutions
Ng, P. C., & Henikoff, S. (2001) · Genome Research · doi:10.1101/gr.176601 · Cited by 2,368
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Scheet, P., & Stephens, M. (2006) · The American Journal of Human Genetics · doi:10.1086/502802 · Cited by 1,941
Self-citationMaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes
Li, Y., Willer, C. J., Ding, J., Scheet, P., & Abecasis, G. R. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20533 · Cited by 1,843
Self-citationTreating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Self-citationCommon and rare variants in multifactorial susceptibility to common diseases
Bodmer, W., & Bonilla, C. (2008) · Nature Genetics · doi:10.1038/ng.f.136 · Cited by 1,131
Impact of OATP transporters on pharmacokinetics
Kalliokoski, A., & Niemi, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00430.x · Cited by 995
Silverman, L. B. (2001) · Blood · doi:10.1182/blood.v97.5.1211 · Cited by 865
González-Pérez, A., & López-Bigas, N. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.004 · Cited by 765
Mammen, A. L., Chung, T., Christopher-Stine, L., Rosen, P., Rosen, A., Doering, K. R., & Casciola-Rosen, L. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30156 · Cited by 699
Niemi, M., Pasanen, M. K., & Neuvonen, P. J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002857 · Cited by 633
Tirona, R. G., Leake, B. F., Merino, G., & Kim, R. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103792200 · Cited by 626
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g156 · Cited by 620
Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia
Evans, W. E., Relling, M. V., Rodman, J. H., Crom, W. R., Boyett, J. M., & Pui, C.-H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380803 · Cited by 492
Self-citationBischoff, K. B., Dedrick, R. L., Zaharko, D. S., & Longstreth, J. A. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600803 · Cited by 480
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Pasanen, M. K., Neuvonen, M., Neuvonen, P. J., & Niemi, M. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230416.82349.90 · Cited by 470
SNPs3D: Candidate gene and SNP selection for association studies
Yue, P., Melamud, E., & Moult, J. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-166 · Cited by 464
Pui, C.-H., Sandlund, J. T., Pei, D., Campana, D., Rivera, G. K., Ribeiro, R. C., Rubnitz, J. E., Razzouk, B. I., Howard, S. C., Hudson, M. M., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1616 · Cited by 463
Self-citationStatistical analysis strategies for association studies involving rare variants
Bansal, V., Libiger, O., Torkamani, A., & Schork, N. J. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2867 · Cited by 455
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068056 · Cited by 443
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia
Johansen, C. T., Wang, J., Lanktree, M. B., Cao, H., McIntyre, A. D., Ban, M. R., Martins, R. A., Kennedy, B. A., Hassell, R. G., Visser, M. E., et al. (2010) · Nature Genetics · doi:10.1038/ng.628 · Cited by 437
Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin
Pasanen, M. K., Fredrikson, H., Neuvonen, P. J., & Niemi, M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100220 · Cited by 432
Niemi, M., Schaeffeler, E., Lang, T., Fromm, M. F., Neuvonen, M., Kyrklund, C., Backman, J. T., Kerb, R., Schwab, M., Neuvonen, P. J., et al. (2004) · Pharmacogenetics · doi:10.1097/01.fpc.0000114750.08559.32 · Cited by 418
SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid
Tornio, A., Vakkilainen, J., Neuvonen, M., Backman, J. T., Neuvonen, P. J., & Niemi, M. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000148 · Cited by 409
Clinical Pharmacodynamics of High-Dose Methotrexate in Acute Lymphocytic Leukemia
Evans, W. E., Crom, W. R., Abromowitch, M., Dodge, R., Look, A. T., Bowman, W. P., George, S. L., & Pui, C.-H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140803 · Cited by 392
Self-citationKameyama, Y., Yamashita, K., Kobayashi, K., Hosokawa, M., & Chiba, K. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000170913.73780.5f · Cited by 379
Cohen, J. C., Pertsemlidis, A., Fahmi, S., Esmail, S., Vega, G. L., Grundy, S. M., & Hobbs, H. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508483103 · Cited by 378
NIEMI, M., BACKMAN, J., KAJOSAARI, L., LEATHART, J., NEUVONEN, M., DALY, A., EICHELBAUM, M., KIVISTO, K., & NEUVONEN, P. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.01.018 · Cited by 360
Treviño, L. R., Shimasaki, N., Yang, W., Panetta, J. C., Cheng, C., Pei, D., Chan, D., Sparreboom, A., Giacomini, K. M., Pui, C.-H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4156 · Cited by 349
Self-citationAbe, T., Unno, M., Onogawa, T., Tokui, T., Kondo, T. N., Nakagomi, R., Adachi, H., Fujiwara, K., Okabe, M., Suzuki, T., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.24804 · Cited by 345
Nozawa, T., Minami, H., Sugiura, S., Tsuji, A., & Tamai, I. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001909 · Cited by 316
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia
Yang, J. J., Cheng, C., Devidas, M., Cao, X., Fan, Y., Campana, D., Yang, W., Neale, G., Cox, N. J., Scheet, P., et al. (2011) · Nature Genetics · doi:10.1038/ng.763 · Cited by 274
Self-citationRare Variant Association Analysis Methods for Complex Traits
Asimit, J., & Zeggini, E. (2010) · Annual Review of Genetics · doi:10.1146/annurev-genet-102209-163421 · Cited by 267
Genome-wide association meta-analysis for total serum bilirubin levels
Johnson, A. D., Kavousi, M., Smith, A. V., Chen, M.-H., Dehghan, A., Aspelund, T., Lin, J.-P., van Duijn, C. M., Harris, T. B., Cupples, L. A., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp202 · Cited by 238
A Genomewide Admixture Mapping Panel for Hispanic/Latino Populations
Mao, X., Bigham, A. W., Mei, R., Gutierrez, G., Weiss, K. M., Brutsaert, T. D., Leon-Velarde, F., Moore, L. G., Vargas, E., McKeigue, P. M., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518564 · Cited by 235
van de Steeg, E., Wagenaar, E., van der Kruijssen, C. M. M., Burggraaff, J. E. C., de Waart, D. R., Elferink, R. P. J. O., Kenworthy, K. E., & Schinkel, A. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42168 · Cited by 226
Neuvonen, P. J., Backman, J. T., & Niemi, M. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847070-00003 · Cited by 216
Ancestry and pharmacogenetics of antileukemic drug toxicity
Kishi, S., Cheng, C., French, D., Pei, D., Das, S., Cook, E. H., Hijiya, N., Rizzari, C., Rosner, G. L., Frudakis, T., et al. (2007) · Blood · doi:10.1182/blood-2006-10-054528 · Cited by 205
Self-citationDonnelly, L. A., Doney, A. S. F., Tavendale, R., Lang, C. C., Pearson, E. R., Colhoun, H. M., McCarthy, M. I., Hattersley, A. T., Morris, A. D., & Palmer, C. N. A. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.255 · Cited by 203
Brunham, L. R., Lansberg, P. J., Zhang, L., Miao, F., Carter, C., Hovingh, G. K., Visscher, H., Jukema, J. W., Stalenhoef, A. F., Ross, C. J. D., et al. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.92 · Cited by 199
Momozawa, Y., Mni, M., Nakamura, K., Coppieters, W., Almer, S., Amininejad, L., Cleynen, I., Colombel, J.-F., de Rijk, P., Dewit, O., et al. (2011) · Nature Genetics · doi:10.1038/ng.733 · Cited by 189
Global Analysis of Genetic Variation in SLCO1B1
Pasanen, M. K., Neuvonen, P. J., & Niemi, M. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.19 · Cited by 183
Hartkoorn, R. C., Kwan, W. S., Shallcross, V., Chaikan, A., Liptrott, N., Egan, D., Sora, E. S., James, C. E., Gibbons, S., Bray, P. G., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328335b02d · Cited by 176
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
Romaine, S. P. R., Bailey, K. M., Hall, A. S., & Balmforth, A. J. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.54 · Cited by 170
Sequence‐based prediction of pathological mutations
Ferrer‐Costa, C., Orozco, M., & de la Cruz, X. (2004) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20252 · Cited by 163
Iwai, M., Suzuki, H., Ieiri, I., Otsubo, K., & Sugiyama, Y. (2004) · Pharmacogenetics · doi:10.1097/00008571-200411000-00006 · Cited by 147
Tachibana-Iimori, R., Tabara, Y., Kusuhara, H., Kohara, K., Kawamoto, R., Nakura, J., Tokunaga, K., Kondo, I., Sugiyama, Y., & Miki, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.375 · Cited by 144
Niemi, M., Kivistö, K. T., Hofmann, U., Schwab, M. G., Eichelbaum, M. F., & Fromm, M. F. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02354.x · Cited by 135
Influence of OATP1B1 Genotype on the Pharmacokinetics of Rosuvastatin in Koreans
Choi, J., Lee, M., Cho, J.-Y., Lee, J.-E., Kim, K. H., & Park, K. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100267 · Cited by 131
Influence of Drug Transporter Polymorphisms on Pravastatin Pharmacokinetics in Humans
Kivistö, K. T., & Niemi, M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9159-2 · Cited by 130
Niemi, M., Neuvonen, P. J., Hofmann, U., Backman, J. T., Schwab, M. G., Lütjohann, D., von Bergmann, K., Eichelbaum, M. F., & Kivistö, K. T. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200505000-00005 · Cited by 125
Deng, J. W., Song, I., Shin, H. J., Yeo, C., Cho, D., Shon, J., & Shin, J. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282fb02a3 · Cited by 125
van de Steeg, E., van der Kruijssen, C. M. M., Wagenaar, E., Burggraaff, J. E. C., Mesman, E. M., Kenworthy, K. E., & Schinkel, A. H. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024315 · Cited by 125
Pasanen, M. K., Backman, J. T., Neuvonen, P. J., & Niemi, M. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0123-1 · Cited by 119
Evans, W., Stewart, C., Chen, C., Crom, W., Bowman, W. P., Abromowitch, M., & Simone, J. V. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90411-2 · Cited by 118
Self-citationLubomirov, R., di Iulio, J., Fayet, A., Colombo, S. F., Martínez, R., Marzolini, C., Furrer, H., Vernazza, P., Calmy, A., Cavassini, M. L., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328336eee4 · Cited by 116
Zaïr, Z. M., Eloranta, J. J., Stieger, B., & Kullak-Ublick, G. A. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.597 · Cited by 115
Buch, S., Schafmayer, C., Völzke, H., Seeger, M., Miquel, J. F., Sookoian, S. C., Egberts, J. H., Arlt, A., Pirola, C. J., Lerch, M. M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.003 · Cited by 113
Han, J., Lim, H., Park, Y. H., Lee, S., & Lee, J. S. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.12.003 · Cited by 107
Bailey, K. M., Romaine, S. P. R., Jackson, B. M., Farrin, A. J., Efthymiou, M., Barth, J. H., Copeland, J., McCormack, T., Whitehead, A. L., Flather, M. D., et al. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.898502 · Cited by 106
Pharmacogenetics of Drug Transporters
Franke, R. M., Gardner, E. R., & Sparreboom, A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161210790112683 · Cited by 103
Self-citationEffect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide
Zhang, W., He, Y., Han, C., Liu, Z., Li, Q., Fan, L., Tan, Z., Zhang, W., Yu, B., Wang, D., et al. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02686.x · Cited by 101
Cerivastatin, Genetic Variants, and the Risk of Rhabdomyolysis
Marciante, K., Durda, J. P., Heckbert, S., Lumley, T., Rice, K., McKnight, B., Totah, R., Tamraz, B., Kroetz, D., Fukushima, H., et al. (2011) · Pharmacogenetics & Genomics · doi:10.1097/fpc.0b013e328343dd7d · Cited by 100
Kalliokoski, A., Neuvonen, M., Neuvonen, P. J., & Niemi, M. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007311569 · Cited by 99
A Genome-wide Comparison of the Functional Properties of Rare and Common Genetic Variants in Humans
Zhu, Q., Ge, D., Maia, J. M., Zhu, M., Petrovski, S., Dickson, S. P., Heinzen, E. L., Shianna, K. V., & Goldstein, D. B. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.008 · Cited by 96
Martino, M. T. D., Arbitrio, M., Leone, E., Guzzi, P. H., Rotundo, M. S., Ciliberto, D., Tomaino, V., Fabiani, F., Talarico, D., Sperlongano, P., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.9.17781 · Cited by 95
Yang, W., Treviño, L. R., Yang, J. J., Scheet, P. A., Pui, C., We, E., & Relling, M. V. (2010) · Leukemia · doi:10.1038/leu.2009.277 · Cited by 94
Self-citationCouvert, P., Giral, P., Dejager, S., Gu, J. Z., Huby, T., Chapman, M. J., Bruckert, É., & Carrié, A. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.9.1217 · Cited by 90
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism
He, Y., Zhang, W., Chen, Y., Guo, D., Tu, J., Xu, L., Tan, Z., Chen, B., Li, Z., Zhou, G., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.04.003 · Cited by 88
Kohlrausch, F. B., Estrela, R. D. C. E., Barroso, P. F., & Suarez‐Kurtz, G. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03551.x · Cited by 76
Zhang, W., Chen, B., Özdemir, V., He, Y., Zhou, G., Peng, D.-D., Deng, S., Xie, Q., Xie, W., Xu, L., et al. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02892.x · Cited by 74
Genetic Architecture of Ambulatory Blood Pressure in the General Population
Tomaszewski, M., Dębiec, R., Braund, P. S., Nelson, C. P., Hardwick, R. J., Christofidou, P., Denniff, M. J., Codd, V., Rafelt, S. E., van der Harst, P., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.155721 · Cited by 71
Santos, P. C. J. L., Gagliardi, A. C. M., Miname, M. H., Chacra, A. P. M., Santos, R. D., Krieger, J. E., & Pereira, A. C. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1125-1 · Cited by 70
The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range
Kalliokoski, A., Neuvonen, M., Neuvonen, P. J., & Niemi, M. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03287.x · Cited by 70
Gender Is an Important Determinant of the Disposition of the Loop Diuretic Torasemide
Werner, U., Werner, D., Heinbüchner, S., Graf, B., İnce, H., Kische, S., Thürmann, P., König, J., Fromm, M. F., & Zolk, O. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009337514 · Cited by 66
Kalliokoski, A., Neuvonen, M., Neuvonen, P. J., & Niemi, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02986.x · Cited by 61
Liu, D. J., & Leal, S. M. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.025 · Cited by 59
Ni, W., Ji, J., Dai, Z., Papp, A. C., Johnson, A. J., Ahn, S., Farley, K. L., Lin, T. S., Dalton, J. T., Li, X., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013792 · Cited by 57
Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations
Mwinyi, J., Köpke, K., Schaefer, M., Roots, I., & Gerloff, T. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0409-y · Cited by 54
Hedman, M., Antikainen, M., Holmberg, C., Neuvonen, M., Eichelbaum, M. F., Kivistö, K. T., Neuvonen, P. J., & Niemi, M. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02643.x · Cited by 54
Weaver, Y. M., & Hagenbuch, B. (2010) · The Journal of Membrane Biology · doi:10.1007/s00232-010-9300-3 · Cited by 53
The role of vitamin D and SLCO1B1 gene polymorphism in statin-associated myalgias
Linde, R., Peng, L., Desai, M., & Feldman, D. (2010) · Dermato-Endocrinology · doi:10.4161/derm.2.2.13509 · Cited by 44
Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
Tomalik‐Scharte, D., Fuhr, U., Hellmich, M., Frank, D., Doroshyenko, O., Jetter, A., & Stingl, J. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.036921 · Cited by 43
SLCO1B1Polymorphism and Oral Antidiabetic Drugs
Kalliokoski, A., Neuvonen, P. J., & Niemi, M. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00581.x · Cited by 42
Carr, D. F., Whiteley, G., Alfirevic, A., Pirmohamed, M., & on behalf of the FolATED study team (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.29 · Cited by 41
Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients
Xu, L., He, Y., Zhang, W., Deng, S., Li, Q., Zhang, W., Liu, Z., Wang, D., Huang, Y., Zhou, H., et al. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00643.x · Cited by 41
Aklillu, E., Mugusi, S. F., Ngaimisi, E., Hoffmann, M. M., König, S. K., Ziesenitz, V. C., Mikus, G., Haefeli, W. E., & Weiß, J. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1065-9 · Cited by 37
Rakhmanina, N. Y., Neely, M. N., van Schaik, R. H. N., Gordish‐Dressman, H., Williams, K., Soldin, S. J., & van den Anker, J. N. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318225384f · Cited by 36
Gerloff, T., Schaefer, M., Mwinyi, J., Johne, A., Sudhop, T., Lütjohann, D., Roots, I., & von Bergmann, K. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0053-6 · Cited by 31
Yang, G.-P., Yuan, H., Tang, B., Zhang, W., Wang, L., Huang, Z., Ouyang, D., Zhang, G., & Zhou, H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.203 · Cited by 30
Kim, E., Cho, D., Shin, H. J., Lee, S., Shon, J., Shin, J., & Shin, S.-G. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.010 · Cited by 29
Pharmacogenomics: will the promise be fulfilled?
Altman, R. B., Kroemer, H. K., McCarty, C. A., Ratain, M. J., & Roden, D. M. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2920 · Cited by 24
Lee, E., Schumacher, F. R., Lewinger, J. P., Neuhausen, S. L., Anton‐Culver, H., Horn‐Ross, P. L., Henderson, K. D., Ziogas, A., Berg, D. V. D., Bernstein, L., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2859 · Cited by 21
Srivastava, A., Srivastava, A., Srivastava, N., Choudhuri, G., & Mittal, B. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00736.x · Cited by 17
Prevalence of risk factors for statin‐induced myopathy in rheumatoid arthritis patients
Toms, T. E., Smith, J., Panoulas, V. F., Douglas, K., Saratzis, A. N., & Kitas, G. D. (2009) · Musculoskeletal Care · doi:10.1002/msc.160 · Cited by 12
Non-synonymous polymorphisms in the human SLCO1B1 gene: an in vitro analysis of SNP c.1929A>C
Seithel‐Keuth, A., Klein, K., Zanger, U. M., Fromm, M. F., & König, J. (2007) · Molecular Genetics and Genomics · doi:10.1007/s00438-007-0303-4 · Cited by 12
Jindal, C., Kumar, S., Choudhari, G. C. M. K. A., Goel, H., & Mittal, B. (2009) · PubMed · Cited by 11
Lin, R., Wang, X., Zhou, W., Fu, W., Wang, Y., Huang, W., & Li, J. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2010.00622.x · Cited by 8
Genetic Marker of Statin-induced Rhabdomyolysis
Chiba, K., & Morimoto, K. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.247 · Cited by 3
Cited by
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Pui, C.-H., Yang, J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., Vora, A., Baruchel, A., Silverman, L. B., Schmiegelow, K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1636 · Cited by 1,007
Self-citationPreventing and Managing Toxicities of High-Dose Methotrexate
Howard, S. C., McCormick, J., Pui, C.-H., Buddington, R. K., & Harvey, R. D. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0164 · Cited by 929
Self-citationRamsey, L. B., Johnson, S. G., Caudle, K. E., Haidar, C. E., Voora, D., Wilke, R. A., Maxwell, W. D., McLeod, H. L., Krauss, R. M., Roden, D. M., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.125 · Cited by 433
Self-citationSLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid
Tornio, A., Vakkilainen, J., Neuvonen, M., Backman, J. T., Neuvonen, P. J., & Niemi, M. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000148 · Cited by 409
Metadata
- Authors
- Ramsey, L. B., Bruun, G. H., Yang, W., Treviño, L. R., Vattathil, S., Scheet, P., Cheng, C., Rosner, G. L., Giacomini, K. M., Fan, Y., Sparreboom, A., Mikkelsen, T. S., Corydon, T. J., Pui, C.-H., Evans, W. E., & Relling, M. V.
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-12-06
- Volume
- 22
- Issue
- 1
- Pages
- 1-8
- ISSN
- 1088-9051 (ISSN-L)
- OpenAlex
- W2005615400
- Cited by
- 261
- References
- 104
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.